Monocarboxylate transporter 1 enhancing the expression of inducible nitric oxide synthase within M1 phenotype microglia under low-glucose condition&nbsp;

ZHOU Peng; YU Zhe-Cheng; ZHANG Xiao-Yan; YANG Song-Yuan; DU Juan-Juan

doi:10.16098/j.issn.0529-1356.2022.03.003

PDF(4013 KB)

Acta Anatomica Sinica ›› 2022, Vol. 53 ›› Issue (3) : 288-294. DOI: 10.16098/j.issn.0529-1356.2022.03.003

Monocarboxylate transporter 1 enhancing the expression of inducible nitric oxide synthase within M1 phenotype microglia under low-glucose condition

YU Zhe-cheng¹ ZHANG Xiao-yan² DU Juan-juan¹ ZHOU Peng^1*

Author information +

History +

Abstract

Objective To testify the link between the increase of inducible nitric oxide synthase (iNOS) and monocarboxylate transporter 1 (MCT1) expression in the M1 phenotype microglia under ischemic condition. Methods Photothrombosic ischemia stroke model was applied in 6 mice. BV2 cells were treated with low glucose medium contained 5mmol/L glucose for 2 hours. Immunofluorescent staining and Western blotting were used to check the responses from microglia in the mouse brains subjected to ischemia and BV2 cells were treated with low-glucose treatment. Application of RNA interference or plasmid transfection were used to regulate the MCT1 expression in BV2 cells. Results The expression levels of iNOS, MCT1 and arginase-1 (ARG1) increased in the ischemic side compared to the non-ischemic side of mice brain(P<0.01). In the BV2 cells exposed to low-glucose condition, iNOS and MCT1 levels increased(P<0.001), whereas ARG1 level decreased(P<0.01). RNA interference interfered the expression of MCT1 and then decreased the iNOS expression(P<0.01), while overexpression of MCT1 through plasmid transfection increased iNOS expression(P<0.01), while the ARG1 expressions in both conditions were not changed significantly. Conclusion After microglia polarized into inflammatory phenotype during ischemia period, iNOS production is related with MCT1 expression, and MCT1 is in the upstream of iNOS pathway.

Key words

Inducible nitric oxide synthase / Monocarboxylate transporter 1 / Ischemic stroke / Microglia / Photochemical embolization / Western blotting / Mouse

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

YU Zhe-cheng ZHANG Xiao-yan DU Juan-juan ZHOU Peng. Monocarboxylate transporter 1 enhancing the expression of inducible nitric oxide synthase within M1 phenotype microglia under low-glucose condition [J]. Acta Anatomica Sinica. 2022, 53(3): 288-294 https://doi.org/10.16098/j.issn.0529-1356.2022.03.003

References

［1］Wolf SA, Boddeke HW, Kettenmann H. Microglia in Physiology and Disease［J］. Annu Rev Physiol, 2017, 79:619-643.

［2］Collmann FM, Pijnenburg R,Hamzei-Taj S,et al. Individual in vivo profiles of microglia polarization after stroke, represented by the genes iNOS and Ym1［J］. Front Immunol,2019,10:1236.

［3］Liddelow SA,Guttenplan KA,ClarkeK LE,et al. Neurotoxic reactive astrocytes are induced by activated microglia［J］. Nature,2017,541(7638): 481-487.

［4］Tang Y, Le W. Differential roles of M1 and M2 microglia in neurodegenerative diseases［J］. Mol Neurobiol,2015, 53(2):1181-1194.

［5］Yeh FL, Hansen DV, Sheng M. TREM2, microglia, and neurodegenerative diseases［J］. Trends Mol Med,2017,23(6): 512-533.

［6］Kierdorf K, Prinz M. Microglia: same same, but different［J］. J Exp Med, 2019,2169(10): 2223-2225.

［7］Colonna M,Butovsky O. Microglia function in the central nervous system during health and neurodegeneration［J］. Annu Rev Immunol,2017,35:441-468.

［8］Zhao B, Wang H, Li CX, et al. GPR17 mediates ischemia-like neuronal injury via microglial activation［J］. Int J Mol Med,2018, 42(5): 2750-2762.

［9］Shen Y, Kapfhamer D, Minnella AM, et al. Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP［J］. Nat Commun,2017,8(1): 624.

［10］Ghosh S, Castillo E, Frias ES, et al. Bioenergetic regulation of microglia［J］. Glia,2017, 66(6):1200-1212.

［11］Galván-Pe?a S, O’Neill LA. Metabolic reprograming in macrophage polarization［J］. Front Immunol,2014, 5:420.

［12］Salter MW, Stevens B. Microglia emerge as central players in brain disease［J］. Nat Med,2017, 23(9): 1018-1027.

［13］Hashimoto T, Hussien R,Cho HS, et al. Evidence for the mitochondrial lactate oxidation complex in rat neurons: demonstration of an essential component of brain lactate shuttles［J］. PLoS One, 2008,3(8): e2915.

［14］Moreira TJ, Maekawa F, Repond C,et al. Enhanced cerebral expression of MCT1 and MCT2 in a rat ischemia model occurs in activated microglial cells［J］, J Cereb Blood Flow Metab,2009, 29(7): 1273-1283.

［15］Kong L, Wang Z, Liang X, et al. Monocarboxylate transporter 1 promotes classical microglial activation and proinflammatory effect via 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase3［J］. J Neuroinflammation, 2019,16(1):240.

［16］Zhao Z,Wu MS, Zou C,et al. Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway［J］.Cancer Letters,2014,342(1)150-158.

［17］Huang C,Lu X, Wang JL, et al. Compound C induces the ramification of murine microglia in an AMPK-independent and small rhogtpase-dependent manner［J］. Neuroscience,2016, 331:24-39.

［18］Subedi L, Lee JH, Yumnam S, et al. Anti-inflammatory effect of sulforaphane on LPS-activated microglia potentially through JNK/AP-1/NF-kB inhibition and Nrf2/HO-1 activation［J］. Cells,2019,8(2):194.

［19］Yang L, Renyuan Zhoua, Yu Tong,et al. Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation［J］. Neurobiol Dis，2020，140：104814.

［20］Du JJ，Ye Zh，Zhou T，et al. Small ubiquitin-like modifier proteins specific protease 3 in microgliaparticipating in the early progression of photothrombosic ischemic stroke mice model［J］. Acta Anatomica Sinica,2021,52(4):548-553.(in Chinese)

杜娟娟，叶蓁，周涛，等.小胶质细胞中小泛素样修饰蛋白特异性蛋白酶3参与小鼠光化学栓塞法缺血性脑卒中早期的疾病进展［J］.解剖学报,2021，52(4)：548-553.

［21］Sickmann HM, Walla AB, Schousboe A, et al. Functional significance of brain glycogen in sustaining glutamatergic neurotransmission［J］. J Neurochem,2009, 109（Suppl 1）: 80-86.

［22］Zhou P,Guan T, Jiang Z,et al. Monocarboxylate transporter 1 and the vulnerability of oligodendrocyte lineage cells to metabolic stresses［J］. CNS Neurosci Ther,2018, 24(2):126-134.

［23］Pereira-Vieira J, Preto A, Casal M, et al. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions［J］. Biol Chem,2019,400(6):787-799.

［24］Yue Y,Stone S,Lin W. Role of nuclear factor kappaB in multiple sclerosis and experimental autoimmune encephalomyelitis［J］. Neural Regen Res,2018,13(9):1507-1515.